Skip to search formSkip to main contentSkip to account menu

GDC-0973

Known as: MEK Inhibitor GDC-0973, XL518 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

AzetidinesPiperidines

Narrower (1)

Cobimetinib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Abstract P6-04-11: Combination of PI3K-AKT-mTOR and MEK-ERK pathway inhibitors overcome acquired resistance to letrozole in ER+ breast cancer models
Background: Approximately 60–70% of breast cancers (BC) express estrogen receptor (ERα) and/or progesterone receptor (PR), the…